SCHEMBL3284458

SCHEMBL3284458

Cc1ccc(N(c2ccc(C)cc2)c2ccc(-c3c4ccccc4c(Br)c4ccccc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.41
GSK3B P49841 1/20 0.34
ADK P55263 1/20 0.34
ALDH1A1 P00352 6/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
PTGS2 P35354 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP2C19 P33261 1/20 0.33
GAA P10253 1/20 0.33
PDE9A O76083 1/20 0.33
PDE1C Q14123 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1262728 0.91 ACHE (0.47) ACHEGSK3BADKALDH1A1SMN1; SMN2
SCHEMBL1818741 0.90 MEN1 (0.34) ACHEGSK3BADKALDH1A1MEN1
SCHEMBL1505829 0.89 ACHE (0.49) ACHEGSK3BADKALDH1A1SMN1; SMN2
SCHEMBL14181758 0.87 ACHE (0.45) ACHEGSK3BADKALDH1A1SMN1; SMN2
SCHEMBL11954097 0.87 ACHE (0.45) ACHEGSK3BADKALDH1A1SMN1; SMN2
SCHEMBL12619868 0.87 ACHE (0.45) ACHEGSK3BADKALDH1A1SMN1; SMN2
SCHEMBL10063931 0.87 ACHE (0.45) ACHEGSK3BADKALDH1A1SMN1; SMN2
SCHEMBL29805090 0.87 L3MBTL1 (0.42) ACHEALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL10064005 0.86 ACHE (0.47) ACHEALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL14160409 0.86 ACHE (0.47) ACHEALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7901793-B2 Organic light-emitting compound and organic light-emitting device containing the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-03-08 US disclosed
US-7901793-B2 Organic light-emitting compound and organic light-emitting device containing the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-03-08 US disclosed
US-7709104-B2 Aminoanthryl derivative-substituted pyrene compound and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2010-05-04 US disclosed
US-7387845-B2 Monoamino compound and organic luminescence device using the same CANON KABUSHIKI KAISHA (JP) 2008-06-17 US disclosed
US-7387845-B2 Monoamino compound and organic luminescence device using the same CANON KABUSHIKI KAISHA (JP) 2008-06-17 US disclosed
US-7387845-B2 Monoamino compound and organic luminescence device using the same CANON KABUSHIKI KAISHA (JP) 2008-06-17 US disclosed
US-20070072002-A1 Organic light-emitting compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-03-29 US disclosed
US-20070072002-A1 Organic light-emitting compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-03-29 US disclosed
US-20060115678-A1 Aminoanthryl derivative-substituted pyrene compound and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2006-06-01 US disclosed
US-20050244670-A1 Monoamino compound and organic luminescence device using the same CANON KABUSHIKI KAISHA (JP) 2005-11-03 US disclosed
WO-2004020388-A1 MONOAMINO COMPOUND AND ORGANIC LUMINESCENCE DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060115678-A1 Aminoanthryl derivative-substituted pyrene compound and organic light-emitting device ALAD, PAH, PPOX ACHE 250/4885GSK3B 4471/4885ADK 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.